Publicaciones en las que colabora con Ana Elena Rodríguez Rodríguez (9)

2024

  1. Renal Disease in Metabolic Syndrome: the Hidden Role of Intrarenal Ischemia

    Kidney International Reports, Vol. 9, Núm. 5, pp. 1419-1428

2023

  1. Decaying kidney function during cirrhosis correlates with remodeling of distal colon aldosterone target gene expression

    American journal of physiology. Gastrointestinal and liver physiology, Vol. 325, Núm. 4, pp. G306-G317

  2. Drastic decline in vasoactive intestinal peptide expression in the suprachiasmatic nucleus in obese mice on a long-term high-fat diet

    Brain Research Bulletin, Vol. 202

2021

  1. Increased SGK1 activity potentiates mineralocorticoid/NaCl-induced kidney injury

    American journal of physiology. Renal physiology, Vol. 320, Núm. 4, pp. F628-F643

2019

  1. Inhibition of the mTOR pathway: A new mechanism of β cell toxicity induced by tacrolimus

    American Journal of Transplantation, Vol. 19, Núm. 12, pp. 3240-3249

2017

  1. Deciphering Tacrolimus-Induced Toxicity in Pancreatic β Cells

    American Journal of Transplantation, Vol. 17, Núm. 11, pp. 2829-2840

2016

  1. Iohexol plasma clearance, a simple and reliable method to measure renal function in conscious mice

    Pflugers Archiv European Journal of Physiology, Vol. 468, Núm. 9, pp. 1587-1594

2015

  1. Glucose homeostasis changes and pancreatic β-cell proliferation after switching to cyclosporin in tacrolimus-induced diabetes mellitus

    Nefrologia, Vol. 35, Núm. 3, pp. 264-272

2013

  1. The higher diabetogenic risk of tacrolimus depends on pre-existing insulin resistance. A study in obese and lean zucker rats

    American Journal of Transplantation, Vol. 13, Núm. 7, pp. 1665-1675